AMY BOND: Open Payments
NPI 1144855289 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$368 in 19 payments from 7 companies in 2025. Trend: 2023 $736 · 2024 $551 · 2025 $368
Food & beverage: $368
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $125 |
| Abbott Laboratories | 2 | $59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
| Novo Nordisk Inc | 2 | $34 |
| Exact Sciences Corporation | 2 | $29 |
| Dexcom, Inc. | 1 | $25 |
Products named: EVENITY, FREESTYLE LIBRE 3, JARDIANCE, Cologuard Collection Kit, Dexcom G6 Transmitter, REPATHA, Wegovy, OTEZLA.
Industry payments across TX — which companies pay providers there.
